CSF2 and neoplasm: Cabozantinib, on the other hand, resulted in a reduced tumor growth (Figure 4), thus pointing to a role for GM-CSF and MDSC recruitment in our model and an explanation for the radioresistance of tumors treated with irradiation alone.